PROSPEKTIVNAYa OTsENKA DINAMIKI PLOShchADI ChERNOY SUBSTANTsII PO DANNYM TRANSKRANIAL'NOY SONOGRAFII U BOL'NYKh S BOLEZN'Yu PARKINSONA

A O Chechetkin , E Yu Fedotova , M A Kravchenko , S N Illarioshkin

Russian Military Medical Academy Reports ›› 2019, Vol. 38 ›› Issue (3 (Прил)) : 165 -166.

PDF
Russian Military Medical Academy Reports ›› 2019, Vol. 38 ›› Issue (3 (Прил)) :165 -166. DOI: 10.17816/rmmar26171
Articles
research-article

PROSPEKTIVNAYa OTsENKA DINAMIKI PLOShchADI ChERNOY SUBSTANTsII PO DANNYM TRANSKRANIAL'NOY SONOGRAFII U BOL'NYKh S BOLEZN'Yu PARKINSONA

Author information +
History +
PDF

Abstract

Cite this article

Download citation ▾
A O Chechetkin, E Yu Fedotova, M A Kravchenko, S N Illarioshkin. PROSPEKTIVNAYa OTsENKA DINAMIKI PLOShchADI ChERNOY SUBSTANTsII PO DANNYM TRANSKRANIAL'NOY SONOGRAFII U BOL'NYKh S BOLEZN'Yu PARKINSONA. Russian Military Medical Academy Reports, 2019, 38(3 (Прил)): 165-166 DOI:10.17816/rmmar26171

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Becker, G. Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography / Becker G., Seufert J., Bogdahn U. et al. // Neurology. - 1995. - V.45. - P.182-184.

[2]

Berg, D. Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson’s disease: Implications for idiopathic and monogenetic forms / Berg D. // Neurochem. Res. - 2007. - V.32. - P.1646-1654.

[3]

Stankiewicz, J. Iron in chronic brain disorders: Imaging and neurotherapeutic implications / Stankiewicz J., Panter S.S., Neema M. et al. // Neurotherapeutics. - 2007. - V.4. - N3. - P.371-386.

[4]

Prestel, J. Predictive value of transcranial sonography in the diagnosis of Parkinson’s disease / Prestel J., Schweitzer K.J., Hofer A. et al. // Mov. Disord. - 2006. - V.21. - P.1763-1765.

[5]

Berardelli, A. EFNS/MDS-ES recommendations for the diagnosis of Parkinson’s disease / Berardelli A., Wenning G.K., Antonini A. et al. // Eur. J. Neurol. - 2013. - V.20. N.1. - P.16-34.

[6]

Федотова, е.Ю. Транскраниальная сонография при болезни Паркинсона / Федотова е.Ю., Чечёткин А.О., Шадрина М.И. и др. // Журн. неврол. и психиатр. - 2011. - №11. - С. 49-55.

[7]

Behnke, S. Long-term course of substantia nigra hyperechogenicity in Parkinson’s disease / Behnke S., Runkel A., Kassar H.A. et al. // Mov. Disord. - 2013. - V.28. - N.4. - P.455-459.

[8]

Berg, D. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease / Berg D., Merz B., Reiners K. et al. // Mov. Disord. - 2005. - V.20. - N.3. - P.383-385.

[9]

Iranzo, A. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder / Iranzo A., Stockner H., Serradell M. et al. // Mov. Disord. - 2014. -V.29. - N.14. - P.1774-1780.

[10]

Mahlknecht, P. Substantia nigra hyperechogenicity as a marker for Parkinson’s disease: a population-based study / Mahlknecht P., Seppi K., Stockner H. et al. // Neurodegener. Dis. - 2013. - V.12. - N.4. - P.212-218.

RIGHTS & PERMISSIONS

Chechetkin A.O., Fedotova E.Y., Kravchenko M.A., Illarioshkin S.N.

PDF

52

Accesses

0

Citation

Detail

Sections
Recommended

/